Related Experiment Video
Updated: Feb 17, 2026

Collection and Extraction of Occupational Air Samples for Analysis of Fungal DNA
Published on: May 2, 2018
State Injury Programs' Response to the Opioid Epidemic: The Role of CDC's Core Violence and Injury Prevention Program
Angela J Deokar1, Alan Dellapenna, Jolene DeFiore-Hyrmer
1Division of Analysis, Research and Practice Integration, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia (Ms Deokar); Injury and Violence Prevention Branch, North Carolina Department of Health and Human Services, Raleigh, North Carolina (Mr Dellapenna), Ohio Violence and Injury Prevention Program, Ohio Department of Health, Columbus, Ohio (Mss Defiore-Hyrmer and Morman); Injury and Violence Prevention Section, Oregon Health Authority, Salem, Oregon (Mr Laidler and Ms Millet); and Violence and Injury Prevention-Mental Health Promotion Branch, Colorado Department of Health and Environment, Denver, Colorado (Ms Myers).
None:
The Centers for Disease Control and Prevention's (CDC's) Core Violence and Injury Prevention Program (Core) supports capacity of state violence and injury prevention programs to implement evidence-based interventions. Several Core-funded states prioritized prescription drug overdose (PDO) and leveraged their systems to identify and respond to the epidemic before specific PDO prevention funding was available through CDC. This article describes activities employed by Core-funded states early in the epidemic. Four case examples illustrate states' approaches within the context of their systems and partners. While Core funding is not sufficient to support a comprehensive PDO prevention program, having Core in place at the beginning of the emerging epidemic had critical implications for identifying the problem and developing systems that were later expanded as additional resources became available. Important components included staffing support to bolster programmatic and epidemiological capacity; diverse and collaborative partnerships; and use of surveillance and evidence-informed best practices to prioritize decision-making.
More Related Videos
12:09Establishing a Liquid-covered Culture of Polarized Human Airway Epithelial Calu-3 Cells to Study Host Cell Response to Respiratory Pathogens In vitro
Published on: February 7, 2013
08:42Immunohistochemistry Test for the Lyssavirus Antigen Detection from Formalin-Fixed Tissues
Published on: October 26, 2021